The Food and Drug Administration on Friday authorized the use of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a move that will make the shots available to 28 million kids in the U.S.
The Centers for Disease Control and Prevention must sign off before shots can be distributed. It’s scheduled an advisory committee meeting to review the pediatric doses next week and is expected to swiftly clear them for public distribution immediately thereafter.
The FDA clearance – which was expected – came after the agency’s Vaccines and Related Biological Products Advisory Committee voted overwhelmingly Tuesday to back a smaller dose of the Pfizer vaccine for young children.
Read the full article.
The FDA has authorized emergency use of the Pfizer vaccine for 5–11 year olds. https://t.co/gmyWjGVmAp
— Kaitlan Collins (@kaitlancollins) October 29, 2021